Published in Clin Infect Dis on January 01, 2007
Clostridium difficile infection: new insights into management. Mayo Clin Proc (2012) 1.23
Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis (2006) 2.35
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States. Antimicrob Agents Chemother (2003) 5.48
Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis (2011) 5.42
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy. N Engl J Med (2009) 4.54
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis (2003) 4.29
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis (2010) 4.06
Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med (2014) 3.48
Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial. JAMA (2006) 3.23
Administrative coding data, compared with CDC/NHSN criteria, are poor indicators of health care-associated infections. Am J Infect Control (2008) 2.38
Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA (2010) 2.23
Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy. Clin Infect Dis (2004) 2.17
Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infect Control Hosp Epidemiol (2012) 2.15
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis (2011) 2.15
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis (2003) 2.04
AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. HIV Clin Trials (2008) 1.99
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s. J Infect Dis (2007) 1.89
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis (2014) 1.78
Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 1.75
Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol (2010) 1.73
Review of infectious diseases applications for iPhone/iPad and Android: from pocket to patient. Clin Infect Dis (2013) 1.61
Improved surveillance for surgical site infections after orthopedic implantation procedures: extending applications for automated data. Clin Infect Dis (2009) 1.35
Independent risk factors for infection in tissue expander breast reconstruction. Plast Reconstr Surg (2009) 1.32
No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clin Infect Dis (2011) 1.32
Multicenter study of surveillance for hospital-onset Clostridium difficile infection by the use of ICD-9-CM diagnosis codes. Infect Control Hosp Epidemiol (2010) 1.29
HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS (2007) 1.25
Multicenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection. Infect Control Hosp Epidemiol (2009) 1.23
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009. Pharmacoepidemiol Drug Saf (2011) 1.23
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii. Pharmacotherapy (2007) 1.21
Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother (2012) 1.18
Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. Infect Control Hosp Epidemiol (2011) 1.16
The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis (2011) 1.16
Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery. Infect Control Hosp Epidemiol (2012) 1.14
Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care (2011) 1.13
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir. J Acquir Immune Defic Syndr (2009) 1.11
Infliximab and reactivation of cerebral toxoplasmosis. N Engl J Med (2005) 1.10
Developing a risk stratification model for surgical site infection after abdominal hysterectomy. Infect Control Hosp Epidemiol (2009) 1.09
Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs? Clin Infect Dis (2012) 1.09
Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report. Infect Control Hosp Epidemiol (2012) 1.07
Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. Clin Infect Dis (2011) 1.04
Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. AIDS (2007) 1.03
Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect (2008) 1.01
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects. J Infect Dis (2009) 1.00
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysis. Oncology (2011) 0.99
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. AIDS (2008) 0.99
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrob Agents Chemother (2007) 0.98
Human N-acetyltransferase 1 *10 and *11 alleles increase protein expression through distinct mechanisms and associate with sulfamethoxazole-induced hypersensitivity. Pharmacogenet Genomics (2011) 0.97
Third-trimester maternal toxicity with nevirapine use in pregnancy. Obstet Gynecol (2005) 0.96
Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections. Crit Care (2013) 0.96
Development of a reference information model and knowledgebase for electronic bloodstream infection detection. AMIA Annu Symp Proc (2008) 0.95
Reactivation of histoplasmosis after treatment with infliximab. Am J Med (2002) 0.94
Characterization of "Mycobacterium paraffinicum" associated with a pseudo-outbreak. J Clin Microbiol (2008) 0.92
Bacterial contamination of stethoscopes with antimicrobial diaphragm covers. Am J Infect Control (2007) 0.89
Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. J Acquir Immune Defic Syndr (2010) 0.88
Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy. Clin Infect Dis (2002) 0.88
Accelerated Longitudinal Gait Speed Decline in HIV-Infected Older Men. J Acquir Immune Defic Syndr (2015) 0.88
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. Am J Clin Nutr (2008) 0.87
Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res (2012) 0.87
Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq. Emerg Infect Dis (2008) 0.86
Assessing specific secondary ICD-9-CM codes as potential predictors of surgical site infections. Am J Infect Control (2010) 0.86
Outbreak of hemodialysis vascular access site infections related to malfunctioning permanent tunneled catheters: making the case for active infection surveillance. Infect Control Hosp Epidemiol (2002) 0.86
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. J Acquir Immune Defic Syndr (2014) 0.85
Peramivir pharmacokinetics in two critically ill adults with 2009 H1N1 influenza A concurrently receiving continuous renal replacement therapy. Pharmacotherapy (2010) 0.85
A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol (2012) 0.85
Colonization with Staphylococcus aureus and methicillin-resistant S. aureus among a sample of homeless individuals, Ohio. Infect Control Hosp Epidemiol (2009) 0.85
An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series. Pharmacotherapy (2014) 0.85
Disagreement between emergency physician and inpatient physician diagnosis of infection in older adults admitted from the emergency department. Acad Emerg Med (2012) 0.84
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS (2007) 0.84
Fulminant Neisseria meningitidis: role for extracorporeal membrane oxygenation. Heart Surg Forum (2010) 0.84
Impact of formulary restriction with prior authorization by an antimicrobial stewardship program. Virulence (2012) 0.84
Methicillin-resistant Staphylococcus aureus sequence type 239-III, Ohio, USA, 2007-2009. Emerg Infect Dis (2012) 0.83
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity. J Acquir Immune Defic Syndr (2004) 0.82
Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatients. J Oral Pathol Med (2002) 0.81
Extracorporeal membrane oxygenation for pandemic (H1N1) 2009. Emerg Infect Dis (2009) 0.81
Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities. Infect Control Hosp Epidemiol (2012) 0.81
Long-term impact of HIV wasting on physical function. AIDS (2016) 0.81
Long-term body composition changes in antiretroviral-treated HIV-infected individuals. AIDS (2016) 0.80
Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patients. AIDS (2009) 0.80
Pseudo-outbreak of "Mycobacterium paraffinicum" infection and/or colonization in a tertiary care medical center. Infect Control Hosp Epidemiol (2009) 0.80
Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV/AIDS patients. BMC Med Genomics (2012) 0.80
Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days. Interact Cardiovasc Thorac Surg (2010) 0.79
Clinical failures of linezolid and implications for the clinical microbiology laboratory. Emerg Infect Dis (2002) 0.79
Urinary tract infections: diagnosis and management in the emergency department. Emerg Med Clin North Am (2008) 0.79
Concerns about "Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study". Clin Infect Dis (2009) 0.79
Hematologic, hepatic, renal, and lipid laboratory monitoring after initiation of combination antiretroviral therapy in the United States, 2000-2010. J Acquir Immune Defic Syndr (2013) 0.78
Infection control and postexposure prophylaxis for the pregnant healthcare worker. Clin Obstet Gynecol (2012) 0.78
Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy. AIDS (2013) 0.77
HIV and asthma, is there an association? Respir Med (2012) 0.77
Pneumococcal immunization in older adults: implications for the long-term-care setting. Infect Control Hosp Epidemiol (2004) 0.76
Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study. AIDS Res Hum Retroviruses (2005) 0.76
Delivering HIV subspecialty care in prisons utilizing telemedicine. Dis Mon (2014) 0.76
Continuity of care in a cohort of HIV-infected former jail detainees. J Correct Health Care (2012) 0.76
Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2017) 0.75
Postvaccination Influenza 2009 H1N1 Respiratory Failure Requiring Extracorporeal Membrane Oxygenation. Case Rep Infect Dis (2011) 0.75